D
Blueprint Medicines Corporation BPMC
$88.42 -$1.59-1.77%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 104.04% 100.93% 60.80% 37.94% 22.22%
Total Other Revenue -- -- -- -- --
Total Revenue 104.04% 100.93% 60.80% 37.94% 22.22%
Cost of Revenue 57.57% -33.00% -19.89% -49.68% -52.18%
Gross Profit 106.55% 114.06% 68.40% 48.97% 33.46%
SG&A Expenses 22.64% 23.23% 22.09% 21.60% 23.41%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -2.01% -4.93% -4.41% -4.92% -0.80%
Operating Income 56.39% 48.03% 32.36% 20.69% 9.53%
Income Before Tax 86.98% 76.95% 62.84% 50.02% 8.38%
Income Tax Expenses 26.76% -68.30% -79.48% -88.73% -81.51%
Earnings from Continuing Operations 86.77% 76.92% 62.92% 50.39% 9.06%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 86.77% 76.92% 62.92% 50.39% 9.06%
EBIT 56.39% 48.03% 32.36% 20.69% 9.53%
EBITDA 58.75% 48.98% 32.77% 21.03% 9.73%
EPS Basic 87.80% 77.64% 63.45% 50.87% 10.38%
Normalized Basic EPS 51.54% 43.89% 29.66% 18.34% 6.77%
EPS Diluted 87.18% 77.08% 62.89% 50.39% 10.40%
Normalized Diluted EPS 52.09% 44.41% 30.18% 18.83% 6.77%
Average Basic Shares Outstanding 3.80% 3.11% 2.39% 1.80% 1.53%
Average Diluted Shares Outstanding 4.71% 4.03% 3.31% 2.72% 1.53%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings